The pharmaceutical industry has gone from being radically indifferent to new technologies and evolutions in scientific understanding to changing regulatory landscapes. This is one of the cases where the increasing global healthcare demands have never been so imperative, especially with the rise in chronic diseases and aging populations. With the progress of breakthroughs in artificial intelligence (AI), gene therapy, precision medicine, and biotechnology, the future of drug development will surely be faster, more efficient, and more personal.

The pharmaceutical industry has gone from being radically indifferent to new technologies and evolutions in scientific understanding to changing regulatory landscapes. This is one of the cases where the increasing global healthcare demands have never been so imperative, especially with the rise in chronic diseases and aging populations. With the progress of breakthroughs in artificial intelligence (AI), gene therapy, precision medicine, and biotechnology, the future of drug development will surely be faster, more efficient, and more personal.